DK1663347T3 - Afereseindretning - Google Patents

Afereseindretning

Info

Publication number: DK1663347T3
Authority: DK; Denmark
Prior art keywords: apheresis device; apharesis; contacted; plasma; blood
Prior art date: 2003-09-12

Application number

DK04761033T

Other languages

English (en)

Inventor

Walter Schmidt

Frank Mattner

Original Assignee

Affiris Forschungs & Entwicklungs Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-12

Filing date

2004-09-13

Publication date

2008-05-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34280361&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1663347(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-09-13 Application filed by Affiris Forschungs & Entwicklungs Gmbh filed Critical Affiris Forschungs & Entwicklungs Gmbh

2008-05-19 Application granted granted Critical

2008-05-19 Publication of DK1663347T3 publication Critical patent/DK1663347T3/da

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
General Health & Medical Sciences (AREA)
Vascular Medicine (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Anesthesiology (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Cell Biology (AREA)
Neurology (AREA)
Medicinal Chemistry (AREA)
Analytical Chemistry (AREA)
Pathology (AREA)
Biodiversity & Conservation Biology (AREA)
Cardiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
General Physics & Mathematics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
Food Science & Technology (AREA)
Hospice & Palliative Care (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
External Artificial Organs (AREA)

DK04761033T 2003-09-12 2004-09-13 Afereseindretning DK1663347T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0144403A AT413336B (de)	2003-09-12	2003-09-12	Apherese-vorrichtung
PCT/AT2004/000311 WO2005025651A1 (de)	2003-09-12	2004-09-13	Apherese-vorrichtung

Publications (1)

Publication Number	Publication Date
DK1663347T3 true DK1663347T3 (da)	2008-05-19

Family

ID=34280361

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04761033T DK1663347T3 (da)	2003-09-12	2004-09-13	Afereseindretning

Country Status (16)

Country	Link
US (2)	US7935252B2 (da)
EP (1)	EP1663347B1 (da)
JP (1)	JP4509113B2 (da)
CN (1)	CN100556472C (da)
AT (2)	AT413336B (da)
AU (1)	AU2004271651B2 (da)
CA (1)	CA2538305C (da)
CY (1)	CY1107911T1 (da)
DE (1)	DE502004005851D1 (da)
DK (1)	DK1663347T3 (da)
ES (1)	ES2298789T3 (da)
HK (1)	HK1096320A1 (da)
HR (1)	HRP20080090T3 (da)
PL (1)	PL1663347T3 (da)
PT (1)	PT1663347E (da)
WO (1)	WO2005025651A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003303198A1 (en)	2002-12-19	2004-07-14	New York University	Method for treating amyloid disease
AT500483B1 (de)	2004-07-13	2006-01-15	Mattner Frank Dr	Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT501621A1 (de) *	2005-03-15	2006-10-15	Mattner Frank Dr	Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung
ES2332846B1 (es) *	2007-10-26	2010-07-08	Grifols, S.A.	Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
WO2009082515A1 (en) *	2007-12-21	2009-07-02	Ge Healthcare Bio-Sciences Ab	Method for sterilization of chemically activated solid support materials
EP2320987A1 (en) *	2008-07-29	2011-05-18	Medtronic, Inc.	Apheresis of a target molecule from cerebrospinal fluid
US20100158893A1 (en) *	2008-12-19	2010-06-24	Baxter International Inc.	Systems and methods for obtaining immunoglobulin from blood
CA2748561C (en)	2008-12-22	2016-11-01	Kaneka Corporation	A.beta. remover, a.beta. removing apparatus and a.beta. removal system
US20110033463A1 (en) *	2009-08-06	2011-02-10	Medtronic, Inc.	Apheresis, administration of agent, or combination thereof
EP2497828A1 (en) *	2011-03-07	2012-09-12	Charité - Universitätsmedizin Berlin	Use of aptamers in therapy and/or diagnosis of autoimmune diseases
RS53496B1 (en)	2011-10-04	2015-02-27	Affiris Ag	PROCEDURE FOR THE DETECTION OF Aβ-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE
US9717841B2 (en)	2012-09-11	2017-08-01	Gary L. McNeil	Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source
PL3166660T3 (pl) *	2014-07-10	2018-07-31	Affiris Ag	Substancje i sposoby do zastosowania w profilaktyce i/lub leczeniu choroby Huntingtona
CA2954687A1 (en)	2014-07-10	2016-01-14	Affiris Ag	Substances and methods for the use in prevention and/or treatment in huntington's disease
CN111201030B (zh)	2017-07-25	2024-11-01	真和制药有限公司	通过阻断tim-3和其配体的相互作用治疗癌症
GB201904810D0 (en) *	2019-04-05	2019-05-22	Cynapsedx Ltd	The treatment of protein aggregation diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57103649A (en) *	1980-12-18	1982-06-28	Asahi Chemical Ind	Sterilized gamma-globulin fixing column
JPH06104122B1 (da) *	1985-09-19	1994-12-21
US5216127A (en) *	1987-11-20	1993-06-01	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	Adsorbent for serum amyloid protein
EP0476721B1 (en) *	1987-11-20	1995-03-01	Kanegafuchi Kagaku Kogyo Kabushiki Kaisha	A method for removing serum amyloid protein
JPH01171638A (ja) *	1987-12-25	1989-07-06	Kanegafuchi Chem Ind Co Ltd	血清アミロイドａ蛋白用吸着体
US5604102A (en) *	1992-04-15	1997-02-18	Athena Neurosciences, Inc.	Methods of screening for β-amyloid peptide production inhibitors
JPH06104122A (ja)	1992-09-21	1994-04-15	Matsushita Electric Ind Co Ltd	ロータリートランス
AU691297B2 (en) *	1994-05-13	1998-05-14	Miltenyi Biotec Gmbh	Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood
DE19515554C2 (de) *	1995-04-27	1999-06-17	Braun Melsungen Ag	Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma
US5868936A (en) *	1996-06-20	1999-02-09	Baxter International Inc.	Affinity membrane system and method of using same
US6787523B1 (en) *	1997-12-02	2004-09-07	Neuralab Limited	Prevention and treatment of amyloidogenic disease
MXPA02008145A (es)	2000-02-24	2004-04-05	Univ Washington	Anticuerpos humanizados que secuestran al peptido beta amiloide.
TWI238251B (en) *	2000-07-13	2005-08-21	Anawrhta Biotech Co Ltd	In-vitro adsorbing device using immunity
AU2002366355A1 (en) *	2001-12-17	2003-06-30	New York State Office Of Mental Health	SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
AU2003303198A1 (en)	2002-12-19	2004-07-14	New York University	Method for treating amyloid disease
AT413945B (de) *	2003-01-14	2006-07-15	Mattner Frank Dr	Impfstoff für die alzheimer-krankheit
AT413946B (de) *	2004-07-13	2006-07-15	Mattner Frank Dr	Impfstoff gegen die alzheimer-krankheit
AT500835B1 (de) *	2004-09-13	2007-12-15	Affiris Forschungs & Entwicklungs Gmbh	Cholinestertransport-protein-mimotop als atherosklerose-medikament

2003
- 2003-09-12 AT AT0144403A patent/AT413336B/de not_active IP Right Cessation
2004
- 2004-09-13 ES ES04761033T patent/ES2298789T3/es not_active Expired - Lifetime
- 2004-09-13 PT PT04761033T patent/PT1663347E/pt unknown
- 2004-09-13 AT AT04761033T patent/ATE382383T1/de active
- 2004-09-13 PL PL04761033T patent/PL1663347T3/pl unknown
- 2004-09-13 DK DK04761033T patent/DK1663347T3/da active
- 2004-09-13 EP EP04761033A patent/EP1663347B1/de not_active Expired - Lifetime
- 2004-09-13 AU AU2004271651A patent/AU2004271651B2/en not_active Ceased
- 2004-09-13 CN CNB2004800303263A patent/CN100556472C/zh not_active Expired - Fee Related
- 2004-09-13 CA CA2538305A patent/CA2538305C/en not_active Expired - Fee Related
- 2004-09-13 JP JP2006525566A patent/JP4509113B2/ja not_active Expired - Fee Related
- 2004-09-13 WO PCT/AT2004/000311 patent/WO2005025651A1/de active IP Right Grant
- 2004-09-13 US US10/571,469 patent/US7935252B2/en not_active Expired - Fee Related
- 2004-09-13 DE DE502004005851T patent/DE502004005851D1/de not_active Expired - Lifetime
2007
- 2007-02-01 HK HK07101139.3A patent/HK1096320A1/xx not_active IP Right Cessation
2008
- 2008-03-04 HR HR20080090T patent/HRP20080090T3/xx unknown
- 2008-03-21 CY CY20081100330T patent/CY1107911T1/el unknown
2011
- 2011-03-17 US US13/049,994 patent/US20110166327A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE502004005851D1 (de)	2008-02-14
CN1867365A (zh)	2006-11-22
US20110166327A1 (en)	2011-07-07
PL1663347T3 (pl)	2008-06-30
WO2005025651A1 (de)	2005-03-24
ES2298789T3 (es)	2008-05-16
PT1663347E (pt)	2008-03-28
AT413336B (de)	2006-02-15
CN100556472C (zh)	2009-11-04
EP1663347A1 (de)	2006-06-07
US7935252B2 (en)	2011-05-03
CA2538305A1 (en)	2005-03-24
ATA14442003A (de)	2005-07-15
CY1107911T1 (el)	2013-09-04
AU2004271651B2 (en)	2009-08-06
JP2007504863A (ja)	2007-03-08
HRP20080090T3 (en)	2008-03-31
ATE382383T1 (de)	2008-01-15
HK1096320A1 (en)	2007-06-01
EP1663347B1 (de)	2008-01-02
CA2538305C (en)	2011-05-24
JP4509113B2 (ja)	2010-07-21
AU2004271651A1 (en)	2005-03-24
US20070026029A1 (en)	2007-02-01

Publication	Publication Date	Title
HK1096320A1 (en)	2007-06-01	Apheresis device
IL258702B (en)	2020-04-30	A pump system for use with organ care systems
DE602005022430D1 (de)	2010-09-02	Medizinproduktsysteme
CY1120741T1 (el)	2019-12-11	Θεραπεια οζωδους σκληρυνσης
DE60308293D1 (de)	2006-10-26	Blutbehandlungskathetereinrichtung
DE60328797D1 (de)	2009-09-24	Blutbehandlungsgerät
EP1800703A4 (en)	2009-06-03	blood dialyzer
DE602004032225D1 (de)	2011-05-26	Stromabwärts-Plasmabehandlungsgerät
BRPI0718146A2 (pt)	2013-11-05	Dispositivos de infusão e métodos
EP1815878A4 (en)	2009-07-15	BLOOD CLEANER
EA201000644A1 (ru)	2011-04-29	Антитела для лечения и профилактики болезни альцгеймера и их применение
IS8142A (is)	2005-11-23	Læknislyf gagnleg til meðferðar á verkjum
DE602005026984D1 (de)	2011-04-28	Chinolin-derivate zur behandlung von latenter tuberkulose
DK2219642T3 (da)	2011-12-05	Silibininbestandel til behandling af hepatitis
EP1913879A4 (en)	2014-04-23	MEDICAL TREATMENT DEVICE
ATE465977T1 (de)	2010-05-15	Fluidbehandlungseinrichtung
EP1862153A4 (en)	2009-04-22	OPHTHALMIC CANNULA
ITMI20030647A1 (it)	2004-10-02	Dispositivo per il trattamento di sangue in circolazione extracorporea
ATE515280T1 (de)	2011-07-15	Vorrichtung zur intermittierenden okklusion des koronarsinus
DK1687297T3 (da)	2014-09-22	Triazindimerer til behandling af autoimmunsygdomme
NO20055563L (no)	2005-11-24	Midler for behandlingen av lavere abdominale lidelser
FI20051207A0 (fi)	2005-11-25	Selän hoitolaite
DK1713438T3 (da)	2008-11-10	Medicinsk sæbe
NO20080495L (no)	2008-03-10	PEG-IFN-alfa og ribavirin for HBV-behandling
ITMI20032341A1 (it)	2005-05-29	Dispositivo di autotrasfusione con unificazione delle procedure da effettuare sul paziente.